Does Doxycycline Interact with Pentobarbital Sodium?
Doxycycline and Pentobarbital Sodium have a moderate drug interaction according to U.S. FDA drug labeling data. Barbiturates shorten doxycycline half-life for up to 2 weeks after discontinuation. Clinical response should be monitored closely if given concurrently. The mechanism involves induction of hepatic microsomal enzymes that metabolize the antibiotic. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Doxycycline Class
- Tetracycline-class Drug
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Doxycycline and Pentobarbital Sodium occurs because induction of hepatic microsomal enzymes that metabolize the antibiotic. Clinically, this means barbiturates shorten doxycycline half-life for up to 2 weeks after discontinuation. clinical response should be monitored closely if given concurrently. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Doxycycline and your doctor is considering prescribing Pentobarbital Sodium (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider